A to Z subjects
Find stories by subject. Use the A-Z options to view other subjects.
M
- Maapliv (amino acids)
- MaaT Pharma
- macular oedema
- major depressive disorder (MDD)
- Malaria
- malignant pleural mesothelioma
- Mantle cell lymphoma (MCL)
- Manuela Herrlein
- maple syrup urine disease (MSUD)
- Marburg virus
- Marc Bailey
- Marc Dunoyer
- Marco Mingolla (Institute of Biomedical Research Antoine Marxer)
- Marco Soriani
- marginal zone lymphoma
- Maria Paola Chiesi
- maridebart cafraglitide
- Marjorie Green
- Mark Dickman (University of Sheffield)
- Mark Graham
- Mark Mintun
- Mark O’Connor
- Marketsandmarkets
- MarkNtel Advisors
- Martin Holst Lange
- Martin Meeson
- Martin Vogel (Janssen)
- Marty Makary
- Mass spectrometry and omics
- Massachusetts Institute of Technology (MIT)
- MasterControl
- Material Identification
- Matt Haines
- Matt Jennings
- Matthew Durdy
- MAVYRET (Glecaprevir/Pibrentasvir)
- Maxearn Limited
- MBV AG
- MDMA
- Medable
- medical cannabis
- Medical Marijuana
- Medical University of South Carolina (MUSC)
- medicinal cannabis
- Medicine and Healthcare products Regulatory Agency (MHRA)
- Medicines and Healthcare products Regulatory Agency
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- Medicines for Europe
- Medicines Patent Pool (MPP)
- Medicxi
- Medipost
- Medi-Tech Insights
- Megan Rose
- Mehmet Oz
- Melanoma
- Melodie Bryce
- Memorial Sloan Kettering Cancer Center (MSK)
- MenABCWY
- Menarini Group
- Mene Pangalos (AstraZeneca)
- meningitis
- meningococcal disease
- Menkes disease
- Mental illness
- MENVEO
- Mercaptopurine
- Merck
- Merck & Co
- Merck & Co Inc.
- Merck and Co
- Merck KGaA
- Merck Research Laboratories
- Mergers & Acquisitions
- Meribel Pharma Solutions
- Merkel cell carcinoma
- Merus
- mesenchymal stem cells
- MET-097i
- MET-233i
- metabolic dysfunction-associated steatohepatitis (MASH)
- metachromatic leukodystrophy (MLD)
- Metastatic breast cancer
- metastatic castration-resistant prostate cancer (CRPC)
- Metastatic melanoma
- metastatic non-small lung cancer (NSCLC)
- metastatic triple-negative breast cancer (mTNBC)
- metformin
- Method development and validation
- Methotrexate
- Metsera
- METTLER TOLEDO
- Mettler-Toledo Thornton
- mFOLFOX6
- Michael Flanagan (Avidity Biosciences)
- Michael Osso
- Michael Young
- Michal Nitka
- Michel Pairet (Boehringer Ingelheim)
- Michelle Mitchell
- Microarrays
- Microbial Biological Manufacturing
- Microbiological Consulting LLC
- microbiome
- Microbiome therapeutics: microscope to medicine
- Microbiomes
- Microparticles
- microRNA
- migraine
- Miguel Hernández University (UMH)
- Mike Doustdar
- Mike Hannay
- Mike Tobyn (Bristol Myers Squibb)
- Mike Tommasco
- Mike Ward
- Mineralys Therapeutics
- Mirati Therapeutics
- Miriam Guest (AstraZeneca)
- mirikizumab
- Mirko Pauli (AbbVie)
- miRNA
- Mirna Vazquez
- mirvetuximab soravtansine
- MMI Associates
- mNexspike
- Models
- Moderna
- Mohit Verma
- Molly McGlaughlin
- Monkeypox
- monoclonal antibodies (mAbs)
- monoclonal antibody
- Monte Rosa Therapeutics
- Mould contamination
- Mounjaro
- Mounjaro (tirzepatide)
- Mount Sinai
- Mourad Mellal (Catalent)
- moxifloxacin
- mResvia (Respiratory Syncytial Virus (RSV) mRNA vaccine)
- mRNA
- mRNA vaccine
- mRNA-1083
- mRNA-1345
- MSD
- mucosal melanoma
- Multiple myeloma
- multiple myeloma (MM)
- Multiple sclerosis
- Multiple Sclerosis (MS)
- Multivariate data analytical techniques (MVA)
- mycophenolate mofetil
- mycosis fungoides
- Myelodysplastic syndrome (MDS)
- myelodysplastic syndromes (MDS)
- myelofibrosis
- myopia
- Myotonic Dystrophy Type 1